Proteoglycan involvement in polyamine uptake

M Belting, S Persson, L A Fransson, M Belting, S Persson, L A Fransson

Abstract

We have evaluated the possible role of proteoglycans in the uptake of spermine by human lung fibroblasts. Exogenous glycosaminoglycans behaved as competitive inhibitors of spermine uptake, the most efficient being heparan sulphate (Ki=0.16+/-0.04 microM). Treatment of fibroblasts with either heparan sulphate lyase, p-nitrophenyl-O-beta-D-xylopyranoside or chlorate reduced spermine uptake considerably, whereas chondroitin sulphate lyase had a limited effect. Inhibition of polyamine biosynthesis with alpha-difluoromethylornithine resulted in an increase of cell-associated heparan sulphate proteoglycans exhibiting higher affinity for spermine. The data indicate a specific role for heparan sulphate proteoglycans in the uptake of spermine by fibroblasts. Spermine uptake by pgsD-677, a mutant Chinese hamster ovary cell defective in heparan sulphate biosynthesis, was only moderately reduced (20%) compared with wild-type cells. Treatment of mutant cells with the above-mentioned xyloside resulted in a greater reduction of endogenous proteoglycan production as well as a higher inhibition of spermine uptake than in wild-type cells. Moreover, treatment with chondroitin sulphate lyase resulted in a selective inhibition of uptake in mutant cells, indicating a role for chondroitin/dermatan sulphate proteoglycans in the uptake of spermine by these cells. Fibroblasts, made growth-dependent on exogenous spermine by alpha-difluoromethylornithine treatment, were growth-inhibited by heparan sulphate or beta-D-xyloside, which might have future therapeutical implications.

References

    1. Science. 1991 Jun 21;252(5013):1705-8
    1. Cell. 1991 Feb 22;64(4):841-8
    1. Annu Rev Biochem. 1991;60:443-75
    1. J Biol Chem. 1992 Jan 5;267(1):150-8
    1. J Cell Biol. 1992 Mar;116(5):1273-81
    1. Nature. 1992 Nov 26;360(6402):355-8
    1. Annu Rev Cell Biol. 1992;8:365-93
    1. Exp Cell Res. 1993 May;206(1):93-9
    1. Cancer Res. 1993 Jun 1;53(11):2618-22
    1. J Cell Biol. 1993 Aug;122(4):933-40
    1. Biochim Biophys Acta. 1993 Sep 19;1151(2):161-7
    1. Glycoconj J. 1993 Dec;10(6):453-60
    1. Annu Rev Pharmacol Toxicol. 1995;35:55-91
    1. FASEB J. 1996 Apr;10(5):598-614
    1. Glycobiology. 1996 Mar;6(2):121-9
    1. Int J Biochem Cell Biol. 1996 Aug;28(8):843-61
    1. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12349-54
    1. J Biol Chem. 1996 Nov 1;271(44):27556-63
    1. Glycobiology. 1997 Feb;7(1):103-12
    1. J Biol Chem. 1998 Oct 2;273(40):26164-70
    1. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2267-71
    1. J Biochem. 1973 Nov;74(5):1069-73
    1. Biochem J. 1975 Dec;151(3):477-89
    1. Biochemistry. 1976 Sep 7;15(18):3932-42
    1. Eur J Biochem. 1980 May;106(1):59-69
    1. Annu Rev Biochem. 1984;53:749-90
    1. Biochem J. 1986 Mar 1;234(2):249-62
    1. Anal Biochem. 1986 Nov 15;159(1):109-13
    1. Cancer Res. 1988 Sep 1;48(17):4807-11
    1. Trends Biochem Sci. 1990 Apr;15(4):153-8
    1. Curr Opin Cell Biol. 1989 Dec;1(6):1201-18
    1. J Cell Physiol. 1991 Jun;147(3):523-30

Source: PubMed

3
Abonneren